logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11129861 B1

PDFFull Text
Date of Patent:
Sep. 28, 2021

Filed:

Jan. 31, 2018

Methods for treating inflammatory diseases

Applicant:

Okchundang Co., Ltd., Daegu, KR;

Inventors:

Seong Min Ku, Busan, KR;

Tae Hun Ku, Busan, KR;

Chul Jong Jung, Ulsan, KR;

Jeong Gyun Seo, Daegu, KR;

Hye Ran Gong, Daegu, KR;

Sae Kwang Ku, Daegu, KR;

Seok Man Park, Daegu, KR;

Ryong Kong, Jeollabuk-do, KR;

Xian Li, Daegu, KR;

Gyung Yun Beik, Daegu, KR;

Yoeng Eun Yu, Daegu, KR;

Hee Jeong Ryu, Daegu, KR;

Gyu Hyeon Kim, Daegu, KR;

Assignee:

OKCHUNDANG CO., LTD., Daegu, KR;

Attorney:

Harness, Dickey & Pierce, P.L.C.

Primary Examiner:

Ralph J Gitomer

Int. Cl.
CPC ...
A61K 36/258 (2006.01); A61K 36/342 (2006.01); A61P 13/12 (2006.01); A61K 36/07 (2006.01); A61K 36/64 (2006.01); A61K 31/70 (2006.01); A61P 17/00 (2006.01); A61P 37/08 (2006.01); A61P 7/00 (2006.01); A61P 11/06 (2006.01); A61P 27/02 (2006.01); A61P 1/02 (2006.01); A61P 27/16 (2006.01); A61P 1/00 (2006.01); A61P 11/00 (2006.01); A61P 1/04 (2006.01); A61P 15/02 (2006.01); A61P 19/06 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01); A61P 1/16 (2006.01); A61P 13/10 (2006.01);
U.S. Cl.
CPC ...
A61K 36/342 (2013.01); A61K 31/70 (2013.01); A61K 36/07 (2013.01); A61K 36/258 (2013.01); A61K 36/64 (2013.01); A61P 1/00 (2018.01); A61P 1/02 (2018.01); A61P 1/04 (2018.01); A61P 1/16 (2018.01); A61P 7/00 (2018.01); A61P 11/00 (2018.01); A61P 11/06 (2018.01); A61P 13/10 (2018.01); A61P 13/12 (2018.01); A61P 15/02 (2018.01); A61P 17/00 (2018.01); A61P 19/02 (2018.01); A61P 19/06 (2018.01); A61P 27/02 (2018.01); A61P 27/16 (2018.01); A61P 29/00 (2018.01); A61P 37/08 (2018.01);
Abstract

The present invention provides a composition containing, as active ingredients,, and Mel for an antitussive, expectorant, or anti-inflammatory action, and a composition for preventing, alleviating, or treating a respiratory disease. The present invention provides a compositions having excellent effects compared with an existing antitussive agent and expectorant agent. The compositions of the present invention are a naturally derived material and has little cytotoxicity, and thus is expected to be safely used as a medicine or food composition having antitussive, expectorant, and anti-inflammatory effects.

Find Patent Forward Citations

Loading…